Share Price and Basic Stock Data
Last Updated: November 8, 2025, 5:31 am
| PEG Ratio | 3.38 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Gillette India Ltd operates in the personal care industry, primarily focusing on shaving products and grooming solutions. The company’s share price stood at ₹9,114, with a market capitalization of ₹29,704 Cr, reflecting a strong position in the market. Over the past fiscal year, Gillette India reported sales of ₹2,477 Cr, marking a growth from ₹2,256 Cr in the previous year. Quarterly revenue trends show consistent performance, with sales recorded at ₹681 Cr for Mar 2024, increasing to ₹767 Cr by Mar 2025. The company has shown resilience in maintaining sales, particularly with a notable rise in the September 2024 quarter, which reached ₹782 Cr. This upward trend aligns with the rising demand for personal grooming products, especially amidst changing consumer preferences towards premium offerings. Overall, Gillette India’s ability to sustain revenue growth amidst competitive pressures indicates a robust business model and effective market strategies.
Profitability and Efficiency Metrics
Gillette India Ltd has demonstrated impressive profitability metrics, with a reported net profit of ₹563 Cr, translating to a remarkable net profit margin of 18.68% for the trailing twelve months. The company’s operating profit margin (OPM) stood at 30%, showcasing efficient cost management. The operating profit for the Mar 2025 period rose to ₹226 Cr, with an OPM of 29% in the same quarter, reflecting an upward trajectory in profitability. The return on equity (ROE) was a significant 41.6%, underscoring the effectiveness of the company in generating shareholder value. Efficiency ratios also illustrate solid performance, as evidenced by a cash conversion cycle (CCC) of -17 days, indicating swift cash flow management. However, the company faces pressure from rising operational expenses, which have increased from ₹1,773 Cr in FY 2022 to ₹1,995 Cr in FY 2024, necessitating ongoing vigilance in cost control to maintain profitability.
Balance Sheet Strength and Financial Ratios
Gillette India’s balance sheet reflects a strong financial position with no borrowings, standing at ₹0 Cr, which highlights the company’s prudent financial management and low leverage. The total reserves reported reached ₹991 Cr as of Mar 2025, indicating a solid foundation for future growth and investment. The company’s current ratio was reported at 1.64, suggesting sufficient liquidity to meet short-term obligations. Additionally, the interest coverage ratio (ICR) was an impressive 75.73x, demonstrating the company’s robust ability to service any potential debt, although it currently operates without any. The price-to-earnings (P/E) ratio of 52.7 indicates a premium valuation, reflecting investor confidence, albeit at a higher risk of price volatility. Furthermore, the price-to-book value (P/BV) ratio of 24.31x indicates a significant market valuation relative to its book value, which may suggest an overvaluation compared to industry norms.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Gillette India Ltd indicates strong promoter confidence, with promoters holding 75% of the equity. This stable ownership structure is critical for long-term strategic decisions and can reassure investors of management continuity. Foreign institutional investors (FIIs) currently hold 4.82% of the shares, a gradual increase from 2.34% in September 2022, reflecting growing interest from international markets. Domestic institutional investors (DIIs) stand at 9.60%, with a slight decline from previous periods, suggesting a cautious approach from domestic investors. The total number of shareholders was reported at 49,531, showing an increase in retail investor participation. However, the decline in DII holdings may raise concerns regarding institutional confidence in the stock’s valuation amidst sector volatility. Overall, the strong promoter holding coupled with increasing FII interest indicates a positive outlook for investor confidence in the company.
Outlook, Risks, and Final Insight
Looking ahead, Gillette India Ltd is well-positioned to capitalize on the growing personal care market, driven by rising consumer spending and a shift towards premium grooming products. However, potential risks include increasing competition from both domestic and international players, which could pressure market share and margins. Additionally, fluctuations in raw material costs could impact profitability, necessitating effective cost management strategies. The company’s high valuation metrics, particularly the P/E ratio, may pose a risk if growth expectations are not met. Conversely, sustained innovation and expansion into new categories could bolster growth prospects. In conclusion, while Gillette India’s financial health and market position are strong, careful monitoring of market dynamics and operational efficiencies will be essential to navigate future challenges and leverage growth opportunities effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Gillette India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 8,914 Cr. | 274 | 388/190 | 125 | 36.9 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 43.3 Cr. | 25.2 | 37.0/23.3 | 84.9 | 63.6 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 97.5 Cr. | 102 | 119/23.4 | 19.4 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 642 Cr. | 423 | 488/204 | 106 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 11,470 Cr. | 312 | 504/268 | 31.3 | 55.8 | 1.12 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 71,027.14 Cr | 1,948.48 | 61.19 | 113.68 | 0.74% | 29.21% | 23.91% | 4.94 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 553 | 620 | 619 | 619 | 619 | 668 | 639 | 681 | 645 | 782 | 686 | 767 | 707 |
| Expenses | 441 | 484 | 493 | 485 | 476 | 530 | 483 | 519 | 470 | 591 | 503 | 542 | 496 |
| Operating Profit | 112 | 136 | 126 | 134 | 144 | 138 | 157 | 161 | 176 | 190 | 183 | 226 | 210 |
| OPM % | 20% | 22% | 20% | 22% | 23% | 21% | 25% | 24% | 27% | 24% | 27% | 29% | 30% |
| Other Income | 2 | 3 | 3 | 12 | 5 | 9 | 7 | 6 | 5 | 7 | 9 | 12 | 7 |
| Interest | 2 | 0 | 3 | 1 | 3 | 1 | 4 | 4 | 4 | 1 | 4 | 3 | 1 |
| Depreciation | 19 | 18 | 19 | 22 | 22 | 20 | 21 | 21 | 21 | 19 | 21 | 25 | 20 |
| Profit before tax | 92 | 120 | 106 | 123 | 124 | 125 | 139 | 143 | 155 | 177 | 167 | 210 | 195 |
| Tax % | 27% | 28% | 30% | 16% | 26% | 26% | 25% | 31% | 25% | 25% | 25% | 24% | 25% |
| Net Profit | 68 | 87 | 74 | 103 | 92 | 93 | 104 | 99 | 116 | 133 | 126 | 159 | 146 |
| EPS in Rs | 20.74 | 26.63 | 22.85 | 31.52 | 28.16 | 28.45 | 31.90 | 30.41 | 35.59 | 40.82 | 38.66 | 48.70 | 44.71 |
Last Updated: August 2, 2025, 1:15 am
Below is a detailed analysis of the quarterly data for Gillette India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 707.00 Cr.. The value appears to be declining and may need further review. It has decreased from 767.00 Cr. (Mar 2025) to 707.00 Cr., marking a decrease of 60.00 Cr..
- For Expenses, as of Jun 2025, the value is 496.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 542.00 Cr. (Mar 2025) to 496.00 Cr., marking a decrease of 46.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 210.00 Cr.. The value appears to be declining and may need further review. It has decreased from 226.00 Cr. (Mar 2025) to 210.00 Cr., marking a decrease of 16.00 Cr..
- For OPM %, as of Jun 2025, the value is 30.00%. The value appears strong and on an upward trend. It has increased from 29.00% (Mar 2025) to 30.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 5.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 25.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 5.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 195.00 Cr.. The value appears to be declining and may need further review. It has decreased from 210.00 Cr. (Mar 2025) to 195.00 Cr., marking a decrease of 15.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 25.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 146.00 Cr.. The value appears to be declining and may need further review. It has decreased from 159.00 Cr. (Mar 2025) to 146.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 44.71. The value appears to be declining and may need further review. It has decreased from 48.70 (Mar 2025) to 44.71, marking a decrease of 3.99.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 4:15 pm
| Metric | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025n n 9m | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,662 | 1,875 | 1,755 | 1,733 | 1,677 | 1,862 | 1,679 | 1,982 | 2,256 | 2,477 | 2,633 | 2,235 | 2,942 |
| Expenses | 1,589 | 1,684 | 1,448 | 1,348 | 1,290 | 1,478 | 1,319 | 1,522 | 1,773 | 1,937 | 1,995 | 1,635 | 2,132 |
| Operating Profit | 73 | 191 | 306 | 385 | 387 | 384 | 360 | 460 | 483 | 540 | 638 | 600 | 809 |
| OPM % | 4% | 10% | 17% | 22% | 23% | 21% | 21% | 23% | 21% | 22% | 24% | 27% | 28% |
| Other Income | 38 | 68 | 50 | 34 | 8 | 11 | 11 | 32 | 7 | 22 | 20 | 27 | 35 |
| Interest | 0 | 5 | 6 | 7 | 7 | 8 | 5 | 5 | 11 | 8 | 13 | 9 | 10 |
| Depreciation | 33 | 39 | 30 | 38 | 42 | 48 | 51 | 58 | 68 | 81 | 83 | 64 | 85 |
| Profit before tax | 78 | 215 | 320 | 374 | 345 | 339 | 314 | 429 | 411 | 473 | 562 | 554 | 750 |
| Tax % | 34% | 26% | 33% | 32% | 34% | 25% | 27% | 28% | 30% | 25% | 27% | 25% | |
| Net Profit | 51 | 158 | 214 | 253 | 229 | 253 | 230 | 310 | 289 | 356 | 412 | 418 | 563 |
| EPS in Rs | 15.78 | 48.53 | 65.73 | 77.67 | 70.29 | 77.62 | 70.64 | 95.25 | 88.79 | 109.15 | 126.35 | 128.17 | 172.89 |
| Dividend Payout % | 95% | 31% | 60% | 211% | 33% | 57% | 69% | 125% | 78% | 78% | 103% | 87% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 4% |
| 3 Years: | 4% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 10% |
| 3 Years: | 11% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 14% |
| 3 Years: | 25% |
| 1 Year: | 17% |
| Return on Equity | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 36% |
| 3 Years: | 39% |
| Last Year: | 42% |
Last Updated: September 4, 2025, 9:25 pm
Balance Sheet
Last Updated: November 9, 2025, 1:30 pm
| Month | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 |
| Reserves | 611 | 710 | 904 | 468 | 662 | 746 | 879 | 756 | 829 | 956 | 939 | 991 | 1,130 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 411 | 468 | 488 | 498 | 515 | 432 | 441 | 606 | 758 | 927 | 859 | 895 | 987 |
| Total Liabilities | 1,054 | 1,210 | 1,424 | 998 | 1,209 | 1,210 | 1,352 | 1,395 | 1,619 | 1,916 | 1,831 | 1,918 | 2,149 |
| Fixed Assets | 173 | 156 | 178 | 214 | 264 | 300 | 296 | 310 | 363 | 389 | 347 | 342 | 322 |
| CWIP | 61 | 63 | 88 | 63 | 40 | 25 | 21 | 72 | 65 | 32 | 26 | 17 | 31 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 821 | 991 | 1,158 | 721 | 904 | 886 | 1,034 | 1,013 | 1,191 | 1,494 | 1,458 | 1,558 | 1,797 |
| Total Assets | 1,054 | 1,210 | 1,424 | 998 | 1,209 | 1,210 | 1,352 | 1,395 | 1,619 | 1,916 | 1,831 | 1,918 | 2,149 |
Below is a detailed analysis of the balance sheet data for Gillette India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 33.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,130.00 Cr.. The value appears strong and on an upward trend. It has increased from 991.00 Cr. (Mar 2025) to 1,130.00 Cr., marking an increase of 139.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 987.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 895.00 Cr. (Mar 2025) to 987.00 Cr., marking an increase of 92.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,149.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,918.00 Cr. (Mar 2025) to 2,149.00 Cr., marking an increase of 231.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 322.00 Cr.. The value appears to be declining and may need further review. It has decreased from 342.00 Cr. (Mar 2025) to 322.00 Cr., marking a decrease of 20.00 Cr..
- For CWIP, as of Sep 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 31.00 Cr., marking an increase of 14.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,797.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,558.00 Cr. (Mar 2025) to 1,797.00 Cr., marking an increase of 239.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,149.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,918.00 Cr. (Mar 2025) to 2,149.00 Cr., marking an increase of 231.00 Cr..
Notably, the Reserves (1,130.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025n n 9m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 73.00 | 191.00 | 306.00 | 385.00 | 387.00 | 384.00 | 360.00 | 460.00 | 483.00 | 540.00 | 638.00 | 600.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 23 | 23 | 27 | 38 | 36 | 41 | 36 | 43 | 47 | 38 | 62 |
| Inventory Days | 104 | 87 | 104 | 103 | 105 | 104 | 136 | 152 | 130 | 127 | 131 | 181 |
| Days Payable | 116 | 116 | 137 | 150 | 173 | 126 | 138 | 169 | 193 | 209 | 212 | 260 |
| Cash Conversion Cycle | 9 | -6 | -10 | -19 | -30 | 15 | 40 | 19 | -20 | -35 | -43 | -17 |
| Working Capital Days | 27 | 49 | -10 | -17 | -18 | 15 | 35 | 14 | -0 | -4 | -7 | 13 |
| ROCE % | 12% | 35% | 39% | 54% | 60% | 48% | 38% | 51% | 51% | 52% | 59% | 56% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Aditya Birla Sun Life ELSS Tax Saver Fund | 464,089 | 2.04 | 305.64 | 464,089 | 2025-04-22 17:25:44 | 0% |
| Aditya Birla Sun Life MNC Fund - Div | 194,572 | 3.57 | 128.14 | 194,572 | 2025-04-22 17:25:44 | 0% |
| Aditya Birla Sun Life MNC Fund - Gr | 194,572 | 3.57 | 128.14 | 194,572 | 2025-04-22 17:25:44 | 0% |
| Nippon India Multi Cap Fund | 190,000 | 0.49 | 125.13 | 190,000 | 2025-04-22 17:25:45 | 0% |
| Nippon India Large Cap Fund | 165,000 | 0.51 | 108.67 | 165,000 | 2025-04-22 13:03:42 | 0% |
| ICICI Prudential India Opportunities Fund | 127,095 | 0.52 | 83.7 | 127,095 | 2025-04-22 17:25:45 | 0% |
| ICICI Prudential Smallcap Fund | 117,482 | 1.04 | 77.37 | 117,482 | 2025-04-22 17:25:45 | 0% |
| ICICI Prudential FMCG Fund - Dividend | 100,459 | 4.44 | 66.16 | 100,459 | 2025-04-22 17:25:45 | 0% |
| ICICI Prudential FMCG Fund - Growth | 100,459 | 4.44 | 66.16 | 100,459 | 2025-04-22 17:25:45 | 0% |
| ICICI Prudential Bharat Consumption Fund | 94,494 | 2.82 | 62.23 | 94,494 | 2025-04-22 17:25:45 | 0% |
Key Financial Ratios
| Month | Mar 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 128.17 | 126.35 | 109.15 | 88.79 | 95.25 |
| Diluted EPS (Rs.) | 128.17 | 126.35 | 109.15 | 88.79 | 95.25 |
| Cash EPS (Rs.) | 147.88 | 151.68 | 133.90 | 109.75 | 112.89 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 313.93 | 298.03 | 303.42 | 264.25 | 242.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 313.93 | 298.03 | 303.42 | 264.25 | 242.10 |
| Dividend / Share (Rs.) | 112.00 | 130.00 | 85.00 | 69.00 | 119.00 |
| Revenue From Operations / Share (Rs.) | 685.74 | 807.94 | 760.06 | 692.28 | 616.58 |
| PBDIT / Share (Rs.) | 192.37 | 200.53 | 172.25 | 150.42 | 151.04 |
| PBIT / Share (Rs.) | 172.65 | 175.17 | 147.49 | 129.44 | 133.39 |
| PBT / Share (Rs.) | 170.04 | 172.52 | 145.10 | 126.21 | 131.78 |
| Net Profit / Share (Rs.) | 128.16 | 126.33 | 109.14 | 88.78 | 95.24 |
| PBDIT Margin (%) | 28.05 | 24.81 | 22.66 | 21.72 | 24.49 |
| PBIT Margin (%) | 25.17 | 21.68 | 19.40 | 18.69 | 21.63 |
| PBT Margin (%) | 24.79 | 21.35 | 19.09 | 18.23 | 21.37 |
| Net Profit Margin (%) | 18.68 | 15.63 | 14.35 | 12.82 | 15.44 |
| Return on Networth / Equity (%) | 40.82 | 42.38 | 35.96 | 33.59 | 39.33 |
| Return on Capital Employeed (%) | 49.53 | 53.26 | 43.68 | 44.66 | 50.06 |
| Return On Assets (%) | 21.77 | 22.48 | 18.56 | 17.98 | 22.24 |
| Asset Turnover Ratio (%) | 1.19 | 1.41 | 1.41 | 1.50 | 1.46 |
| Current Ratio (X) | 1.64 | 1.56 | 1.53 | 1.43 | 1.46 |
| Quick Ratio (X) | 1.06 | 1.04 | 1.03 | 0.87 | 0.76 |
| Inventory Turnover Ratio (X) | 5.26 | 6.52 | 1.73 | 1.60 | 1.48 |
| Dividend Payout Ratio (NP) (%) | 85.81 | 106.84 | 65.04 | 77.71 | 138.57 |
| Dividend Payout Ratio (CP) (%) | 74.37 | 88.98 | 53.01 | 62.85 | 116.91 |
| Earning Retention Ratio (%) | 14.19 | -6.84 | 34.96 | 22.29 | -38.57 |
| Cash Earning Retention Ratio (%) | 25.63 | 11.02 | 46.99 | 37.15 | -16.91 |
| Interest Coverage Ratio (X) | 73.67 | 75.73 | 72.25 | 46.55 | 93.76 |
| Interest Coverage Ratio (Post Tax) (X) | 50.08 | 48.71 | 46.78 | 28.48 | 60.12 |
| Enterprise Value (Cr.) | 25719.18 | 23131.91 | 16107.66 | 16033.26 | 18343.17 |
| EV / Net Operating Revenue (X) | 11.51 | 8.79 | 6.50 | 7.11 | 9.13 |
| EV / EBITDA (X) | 41.02 | 35.40 | 28.69 | 32.71 | 37.27 |
| MarketCap / Net Operating Revenue (X) | 11.70 | 8.97 | 6.69 | 7.24 | 9.21 |
| Retention Ratios (%) | 14.18 | -6.84 | 34.95 | 22.28 | -38.57 |
| Price / BV (X) | 25.55 | 24.31 | 16.75 | 18.96 | 23.46 |
| Price / Net Operating Revenue (X) | 11.70 | 8.97 | 6.69 | 7.24 | 9.21 |
| EarningsYield | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
After reviewing the key financial ratios for Gillette India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Jun 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 128.17. This value is within the healthy range. It has increased from 126.35 (Jun 24) to 128.17, marking an increase of 1.82.
- For Diluted EPS (Rs.), as of Mar 25, the value is 128.17. This value is within the healthy range. It has increased from 126.35 (Jun 24) to 128.17, marking an increase of 1.82.
- For Cash EPS (Rs.), as of Mar 25, the value is 147.88. This value is within the healthy range. It has decreased from 151.68 (Jun 24) to 147.88, marking a decrease of 3.80.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 313.93. It has increased from 298.03 (Jun 24) to 313.93, marking an increase of 15.90.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 313.93. It has increased from 298.03 (Jun 24) to 313.93, marking an increase of 15.90.
- For Dividend / Share (Rs.), as of Mar 25, the value is 112.00. This value exceeds the healthy maximum of 3. It has decreased from 130.00 (Jun 24) to 112.00, marking a decrease of 18.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 685.74. It has decreased from 807.94 (Jun 24) to 685.74, marking a decrease of 122.20.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 192.37. This value is within the healthy range. It has decreased from 200.53 (Jun 24) to 192.37, marking a decrease of 8.16.
- For PBIT / Share (Rs.), as of Mar 25, the value is 172.65. This value is within the healthy range. It has decreased from 175.17 (Jun 24) to 172.65, marking a decrease of 2.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 170.04. This value is within the healthy range. It has decreased from 172.52 (Jun 24) to 170.04, marking a decrease of 2.48.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 128.16. This value is within the healthy range. It has increased from 126.33 (Jun 24) to 128.16, marking an increase of 1.83.
- For PBDIT Margin (%), as of Mar 25, the value is 28.05. This value is within the healthy range. It has increased from 24.81 (Jun 24) to 28.05, marking an increase of 3.24.
- For PBIT Margin (%), as of Mar 25, the value is 25.17. This value exceeds the healthy maximum of 20. It has increased from 21.68 (Jun 24) to 25.17, marking an increase of 3.49.
- For PBT Margin (%), as of Mar 25, the value is 24.79. This value is within the healthy range. It has increased from 21.35 (Jun 24) to 24.79, marking an increase of 3.44.
- For Net Profit Margin (%), as of Mar 25, the value is 18.68. This value exceeds the healthy maximum of 10. It has increased from 15.63 (Jun 24) to 18.68, marking an increase of 3.05.
- For Return on Networth / Equity (%), as of Mar 25, the value is 40.82. This value is within the healthy range. It has decreased from 42.38 (Jun 24) to 40.82, marking a decrease of 1.56.
- For Return on Capital Employeed (%), as of Mar 25, the value is 49.53. This value is within the healthy range. It has decreased from 53.26 (Jun 24) to 49.53, marking a decrease of 3.73.
- For Return On Assets (%), as of Mar 25, the value is 21.77. This value is within the healthy range. It has decreased from 22.48 (Jun 24) to 21.77, marking a decrease of 0.71.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.19. It has decreased from 1.41 (Jun 24) to 1.19, marking a decrease of 0.22.
- For Current Ratio (X), as of Mar 25, the value is 1.64. This value is within the healthy range. It has increased from 1.56 (Jun 24) to 1.64, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has increased from 1.04 (Jun 24) to 1.06, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.26. This value is within the healthy range. It has decreased from 6.52 (Jun 24) to 5.26, marking a decrease of 1.26.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 85.81. This value exceeds the healthy maximum of 50. It has decreased from 106.84 (Jun 24) to 85.81, marking a decrease of 21.03.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 74.37. This value exceeds the healthy maximum of 50. It has decreased from 88.98 (Jun 24) to 74.37, marking a decrease of 14.61.
- For Earning Retention Ratio (%), as of Mar 25, the value is 14.19. This value is below the healthy minimum of 40. It has increased from -6.84 (Jun 24) to 14.19, marking an increase of 21.03.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 25.63. This value is below the healthy minimum of 40. It has increased from 11.02 (Jun 24) to 25.63, marking an increase of 14.61.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 73.67. This value is within the healthy range. It has decreased from 75.73 (Jun 24) to 73.67, marking a decrease of 2.06.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 50.08. This value is within the healthy range. It has increased from 48.71 (Jun 24) to 50.08, marking an increase of 1.37.
- For Enterprise Value (Cr.), as of Mar 25, the value is 25,719.18. It has increased from 23,131.91 (Jun 24) to 25,719.18, marking an increase of 2,587.27.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 11.51. This value exceeds the healthy maximum of 3. It has increased from 8.79 (Jun 24) to 11.51, marking an increase of 2.72.
- For EV / EBITDA (X), as of Mar 25, the value is 41.02. This value exceeds the healthy maximum of 15. It has increased from 35.40 (Jun 24) to 41.02, marking an increase of 5.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.70. This value exceeds the healthy maximum of 3. It has increased from 8.97 (Jun 24) to 11.70, marking an increase of 2.73.
- For Retention Ratios (%), as of Mar 25, the value is 14.18. This value is below the healthy minimum of 30. It has increased from -6.84 (Jun 24) to 14.18, marking an increase of 21.02.
- For Price / BV (X), as of Mar 25, the value is 25.55. This value exceeds the healthy maximum of 3. It has increased from 24.31 (Jun 24) to 25.55, marking an increase of 1.24.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 11.70. This value exceeds the healthy maximum of 3. It has increased from 8.97 (Jun 24) to 11.70, marking an increase of 2.73.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Jun 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gillette India Ltd:
- Net Profit Margin: 18.68%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 49.53% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 40.82% (Industry Average ROE: 23.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 50.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.06
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 48.2 (Industry average Stock P/E: 61.19)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.68%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | P&G Plaza, Cardinal Gracias Road, Mumbai Maharashtra 400099 | investorgil.im@pg.com https://www.gillette.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Anjuly Chib Duggal | Chairperson & Independent Director |
| Mr. Kumar Venkatasubramanian | Managing Director |
| Ms. Srividya Srinivasan | Executive Director & CFO |
| Mr. Srinivas Maruthi Patnam | Executive Director |
| Mr. Pramod Agarwal | Non Executive Director |
| Mr. Sanjay Asher | Independent Director |
| Mr. C P Gurnani | Independent Director |
FAQ
What is the intrinsic value of Gillette India Ltd?
Gillette India Ltd's intrinsic value (as of 09 November 2025) is 5802.21 which is 31.58% lower the current market price of 8,480.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 27,638 Cr. market cap, FY2025-2026 high/low of 11,505/7,412, reserves of ₹991 Cr, and liabilities of 1,918 Cr.
What is the Market Cap of Gillette India Ltd?
The Market Cap of Gillette India Ltd is 27,638 Cr..
What is the current Stock Price of Gillette India Ltd as on 09 November 2025?
The current stock price of Gillette India Ltd as on 09 November 2025 is 8,480.
What is the High / Low of Gillette India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gillette India Ltd stocks is 11,505/7,412.
What is the Stock P/E of Gillette India Ltd?
The Stock P/E of Gillette India Ltd is 48.2.
What is the Book Value of Gillette India Ltd?
The Book Value of Gillette India Ltd is 357.
What is the Dividend Yield of Gillette India Ltd?
The Dividend Yield of Gillette India Ltd is 1.32 %.
What is the ROCE of Gillette India Ltd?
The ROCE of Gillette India Ltd is 56.1 %.
What is the ROE of Gillette India Ltd?
The ROE of Gillette India Ltd is 41.6 %.
What is the Face Value of Gillette India Ltd?
The Face Value of Gillette India Ltd is 10.0.